Clinical Trials Browser

Interventional × SCLC × anlotinib × Clear all

NCT04684017 2020-12-24

Anlotinib Plus Etoposide and Carboplatin as First-line Treatment for Extensive-stage Small Cell Lung Cancer

Phase 2 Unknown

SCLC